FDA approval for Allergan's intraocular lens:
This article was originally published in Clinica
Executive Summary
The FDA has given Allergan the go-ahead to market its Sensar foldable acrylic posterior chamber intraocular lens (IOL) in the US. The product is a next-generation acrylic IOL designed to minimise some of the unwanted side effect associated with current acrylic lenses, said the Irvine, California-based company. The new IOL is delivered into the eye using the company's implantation system called The Unfolder.